208 - The Opioid Epidemic: What’s Next With Purdue Pharma’s $8.3 Billion Settlement and How COVID-19 is Intensifying The Public Health Crisis
Last week, a judge approved the $8.3 billion settlement between the Department of Justice and OxyContin manufacturer Purdue Pharma. Hopkins opioids researcher Dr. Caleb Alexander talks with Stephanie Desmon about expected fallout from the settlement as well as how the COVID-19 pandemic is exacerbating the crisis by disrupting drug markets, shuttering treatment centers, and reducing the chances of Naloxone administration in overdose emergencies.